157 related articles for article (PubMed ID: 25081546)
1. Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients.
Su HC; Haunschild C; Chung K; Komrokian S; Boles S; Sammel MD; DeMichele A
Cancer; 2014 Dec; 120(23):3691-8. PubMed ID: 25081546
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study.
Ünal Ç; Ordu Ç; Özmen T; İlgun AS; Çelebi F; Baysal B; Özkurt E; Duymaz T; Erdoğan İyigün Z; Kurt S; Öztürk MA; Pilancı KN; Alço G; Yararbaş K; Kayan Tapan T; Güven DC; Soybir G; Özmen V
Curr Oncol; 2023 Oct; 30(10):9217-9229. PubMed ID: 37887566
[TBL] [Abstract][Full Text] [Related]
3. Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency.
Cai Y; Zhang Q; Yu K; Wang Q
Biomed Res Int; 2022; 2022():3878359. PubMed ID: 36277874
[TBL] [Abstract][Full Text] [Related]
4. Ovarian Reserve Biomarkers and Menstrual Cycle Length in a Prospective Cohort Study.
Harris BS; Steiner AZ; Jukic AM
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3748-e3759. PubMed ID: 33772306
[TBL] [Abstract][Full Text] [Related]
5. Impact of tamoxifen therapy on fertility in breast cancer survivors.
Shandley LM; Spencer JB; Fothergill A; Mertens AC; Manatunga A; Paplomata E; Howards PP
Fertil Steril; 2017 Jan; 107(1):243-252.e5. PubMed ID: 27887709
[TBL] [Abstract][Full Text] [Related]
6. Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone, and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank.
Irvin SR; Weiderpass E; Stanczyk FZ; Brinton LA; Trabert B; Langseth H; Wentzensen N
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):636-642. PubMed ID: 31932414
[TBL] [Abstract][Full Text] [Related]
7. Beyond Premature Ovarian Insufficiency: Staging Reproductive Aging in Adolescent and Young Adult Cancer Survivors.
Medica ACO; Whitcomb BW; Shliakhsitsava K; Dietz AC; Pinson K; Lam C; Romero SAD; Sluss P; Sammel MD; Su HI
J Clin Endocrinol Metab; 2021 Jan; 106(2):e1002-e1013. PubMed ID: 33141175
[TBL] [Abstract][Full Text] [Related]
8. Markers of ovarian reserve as predictors of future fertility.
Harris BS; Jukic AM; Truong T; Nagle CT; Erkanli A; Steiner AZ
Fertil Steril; 2023 Jan; 119(1):99-106. PubMed ID: 36460524
[TBL] [Abstract][Full Text] [Related]
9. Long-term effect of chemotherapy after ovarian decortication on the ovarian function in women surviving cancer.
Ortiz E; Peña CJ; Hidalgo JJ; Monllor-Tormos A; Zolfaroli I; Vila MJ; Sánchez-Serrano M; Pellicer A; Cano A
J Assist Reprod Genet; 2023 Dec; 40(12):2827-2834. PubMed ID: 37755614
[TBL] [Abstract][Full Text] [Related]
10. Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy.
Yu B; Douglas N; Ferin MJ; Nakhuda GS; Crew K; Lobo RA; Hershman DL
Cancer; 2010 May; 116(9):2099-105. PubMed ID: 20187091
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormones and ovarian reserve: a comprehensive study of women seeking infertility care.
Halici M; Seker ME; Gebedek IY; Gokbak MN; Cetisli AF; Ciftci AB; Konac E; Kopuk SY; Tiras B; Cakiroglu Y
BMC Womens Health; 2023 Nov; 23(1):570. PubMed ID: 37925426
[TBL] [Abstract][Full Text] [Related]
12. Translational Physiology of Anti-Müllerian Hormone: Clinical Applications in Female Fertility Preservation and Cancer Treatment.
Rodgers RJ; Abbott JA; Walters KA; Ledger WL
Front Endocrinol (Lausanne); 2021; 12():689532. PubMed ID: 34557157
[TBL] [Abstract][Full Text] [Related]
13. Ovarian reserve in children with juvenile idiopathic arthritis using biologic disease-modifying anti-rheumatic drugs.
Ozer Y; Yildiz M; Turan H; Tarcin G; Bingol Aydin D; Gunalp A; Haslak F; Kilic Konte E; Aslan E; Koker O; Bayramoglu E; Sahin S; Adrovic A; Barut K; Kasapcopur O; Evliyaoglu O
Clin Rheumatol; 2024 Jan; 43(1):399-406. PubMed ID: 37646858
[TBL] [Abstract][Full Text] [Related]
14. Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women.
Jung S; Allen N; Arslan AA; Baglietto L; Brinton LA; Egleston BL; Falk R; Fortner RT; Helzlsouer KJ; Idahl A; Kaaks R; Lundin E; Merritt M; Onland-Moret C; Rinaldi S; Sánchez MJ; Sieri S; Schock H; Shu XO; Sluss PM; Staats PN; Travis RC; Tjønneland A; Trichopoulou A; Tworoger S; Visvanathan K; Krogh V; Weiderpass E; Zeleniuch-Jacquotte A; Zheng W; Dorgan JF
Fertil Steril; 2017 Apr; 107(4):1012-1022.e2. PubMed ID: 28366409
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Value and Interpretation of Anti-Müllerian Hormone in Women With Cancer.
Anderson RA; Su HI
Front Endocrinol (Lausanne); 2020; 11():574263. PubMed ID: 33117288
[TBL] [Abstract][Full Text] [Related]
16. Self-collected dried blood spots as a tool for measuring ovarian reserve in young female cancer survivors.
Roberts SC; Seav SM; McDade TW; Dominick SA; Gorman JR; Whitcomb BW; Su HI
Hum Reprod; 2016 Jul; 31(7):1570-8. PubMed ID: 27170433
[TBL] [Abstract][Full Text] [Related]
17. Modeling Variation in the Reproductive Lifespan of Female Adolescent and Young Adult Cancer Survivors Using AMH.
Su HI; Kwan B; Whitcomb BW; Shliakhsitsava K; Dietz AC; Stark SS; Martinez E; Sluss PM; Sammel MD; Natarajan L
J Clin Endocrinol Metab; 2020 Aug; 105(8):2740-51. PubMed ID: 32270202
[TBL] [Abstract][Full Text] [Related]
18. Association between serum 25-hydroxyvitamin D and antimüllerian hormone levels in a cohort of African-American women.
Subramanian A; Harmon QE; Bernardi LA; Carnethon MR; Marsh EE; Baird DD; Jukic AMZ
Fertil Steril; 2024 Apr; 121(4):642-650. PubMed ID: 38145700
[TBL] [Abstract][Full Text] [Related]
19. Age-Related Changes in Low Serum Anti-Müllerian Hormone Levels in Female Adolescents: A Single-Center Retrospective Pilot Study.
Jang JH; Moon JH; Lee SM; Lee MH
J Pediatr Adolesc Gynecol; 2024 Jun; 37(3):365-370. PubMed ID: 38253232
[TBL] [Abstract][Full Text] [Related]
20. The role of antimullerian hormone in assessing ovarian damage from chemotherapy, radiotherapy and surgery.
Wong QHY; Anderson RA
Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):391-398. PubMed ID: 30299433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
